USC removes name of Rufus von KleinSmid, a eugenics leader, from prominent building
By Teresa Watanabe and Tomás Mier,
Los Angeles Times
| 06. 12. 2020
The scholar, who is credited with expanding the university’s academic programs and international relations curriculum as president from 1921 to 1947, believed that people with “defects” had no ethical right to parenthood and should be sterilized.
With its soaring arches, international flags and globe-topped tower, the Von KleinSmid Center for International and Public Affairs is one of the most prominent buildings at USC. Its namesake, the late Rufus B. von KleinSmid, has held a place of distinction as the university’s fifth president.
But on Thursday, USC announced it had stripped Von KleinSmid’s name from the building as the university at last reconciled with his disturbing leadership role in California’s eugenics movement.
The scholar, who is credited with expanding the university’s academic programs and international relations curriculum as president from 1921 to 1947, believed that people with “defects” had no ethical right to parenthood and should be sterilized. His “Human Betterment Foundation” was instrumental in supporting the 1909 California legislation that authorized the forced sterilization of those deemed “unfit” — essentially anyone non-white, said Alexandra Minna Stern, a University of Michigan history professor and expert on eugenics.
His active support of eugenics is “at direct odds with USC’s multicultural community and our mission of diversity and inclusion,” President Carol L. Folt announced.
“This moment is our Call...
Related Articles
By Emily Baumgaertner Nunn, The New York Times | 09.08.2026
It is one of biology’s most ingenious rhythms: Every baby is born young. No matter how much wear and tear their parents’ DNA accumulated over their lifetimes, reproduction erases the molecular scars, handing a clean slate to the next generation...
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Jessica Hamzelou, MIT Technology Review | 07.23.2026
When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave...
